➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
McKesson
AstraZeneca
Express Scripts
McKinsey

Last Updated: May 14, 2021

DrugPatentWatch Database Preview

Netupitant; palonosetron hydrochloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for netupitant; palonosetron hydrochloride and what is the scope of patent protection?

Netupitant; palonosetron hydrochloride is the generic ingredient in one branded drug marketed by Helsinn Hlthcare and is included in one NDA. There are ten patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Netupitant; palonosetron hydrochloride has one hundred and fifty-seven patent family members in sixty-five countries.

There are four drug master file entries for netupitant; palonosetron hydrochloride. One supplier is listed for this compound.

Summary for netupitant; palonosetron hydrochloride
International Patents:157
US Patents:10
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 4
Finished Product Suppliers / Packagers: 1
Clinical Trials: 13
DailyMed Link:netupitant; palonosetron hydrochloride at DailyMed
Recent Clinical Trials for netupitant; palonosetron hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Instituto Brasileiro de Controle do CancerPhase 2
Christina RuhlmannPhase 2/Phase 3
George Clinical Pty LtdPhase 3

See all netupitant; palonosetron hydrochloride clinical trials

US Patents and Regulatory Information for netupitant; palonosetron hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Helsinn Hlthcare AKYNZEO netupitant; palonosetron hydrochloride CAPSULE;ORAL 205718-001 Oct 10, 2014 RX Yes Yes   Get Started for $10   Get Started for $10 Y   Get Started for $10
Helsinn Hlthcare AKYNZEO netupitant; palonosetron hydrochloride CAPSULE;ORAL 205718-001 Oct 10, 2014 RX Yes Yes   Get Started for $10   Get Started for $10   Get Started for $10
Helsinn Hlthcare AKYNZEO netupitant; palonosetron hydrochloride CAPSULE;ORAL 205718-001 Oct 10, 2014 RX Yes Yes   Get Started for $10   Get Started for $10 Y Y   Get Started for $10
Helsinn Hlthcare AKYNZEO netupitant; palonosetron hydrochloride CAPSULE;ORAL 205718-001 Oct 10, 2014 RX Yes Yes   Get Started for $10   Get Started for $10   Get Started for $10
Helsinn Hlthcare AKYNZEO netupitant; palonosetron hydrochloride CAPSULE;ORAL 205718-001 Oct 10, 2014 RX Yes Yes   Get Started for $10   Get Started for $10 Y   Get Started for $10
Helsinn Hlthcare AKYNZEO netupitant; palonosetron hydrochloride CAPSULE;ORAL 205718-001 Oct 10, 2014 RX Yes Yes   Get Started for $10   Get Started for $10   Get Started for $10
Helsinn Hlthcare AKYNZEO netupitant; palonosetron hydrochloride CAPSULE;ORAL 205718-001 Oct 10, 2014 RX Yes Yes   Get Started for $10   Get Started for $10 Y   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for netupitant; palonosetron hydrochloride

Country Patent Number Estimated Expiration
Jordan 2294   Get Started for $10
Georgia, Republic of P20022676   Get Started for $10
Poland 2722044   Get Started for $10
Serbia 53869   Get Started for $10
China 106512010   Get Started for $10
Croatia P20000097   Get Started for $10
United Kingdom 2347422   Get Started for $10
>Country >Patent Number >Estimated Expiration

Supplementary Protection Certificates for netupitant; palonosetron hydrochloride

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1035115 CR 2015 00044 Denmark   Get Started for $10 PRODUCT NAME: NETUPITANT; REG. NO/DATE: EU/1/15/1001 20150529
2785706 122020000050 Germany   Get Started for $10 PRODUCT NAME: FOSNETUPITANT; REGISTRATION NO/DATE: C(2020)1804(FINAL) 20200316
1035115 C01035115/01 Switzerland   Get Started for $10 PRODUCT NAME: NETUPITANT; REGISTRATION NO/DATE: SWISSMEDIC 65499 06.11.2015
1035115 PA2015036,C1035115 Lithuania   Get Started for $10 PRODUCT NAME: NETUPITANTAS; REGISTRATION NO/DATE: EU/1/15/1001 20150527
1035115 CA 2015 00044 Denmark   Get Started for $10 PRODUCT NAME: NETUPITANT; REG. NO/DATE: EU/1/15/1001 20150527
1035115 43/2015 Austria   Get Started for $10 PRODUCT NAME: NETUPITANT; REGISTRATION NO/DATE: EU/1/15/1001 20150527
1035115 C300758 Netherlands   Get Started for $10 PRODUCT NAME: NETUPITANT, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH; REGISTRATION NO/DATE: EU/1/15/1001 20150527
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
McKinsey
Harvard Business School
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.